SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-013866
Filing Date
2023-04-21
Accepted
2023-04-21 16:30:57
Documents
3
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A ikt-proxy-2023_pre_14a.htm PRE 14A 1048528
2 GRAPHIC img161020636_0.jpg GRAPHIC 80488
3 GRAPHIC img161020636_1.jpg GRAPHIC 561475
  Complete submission text file 0000950170-23-013866.txt   1929578
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39676 | Film No.: 23836779
SIC: 2836 Biological Products, (No Diagnostic Substances)